-Binayak Das, Team bioXone
The highly-awaited trials for the Covid-19 vaccine formulation by Oxford have yet again been put on hold for a second time this year. The reason behind this has to do with certain safety concerns, as informed to Stat News, on Tuesday. This measure was taken by AstraZeneca Plc. right after they observed potentially hazardous reaction-response, in a trial participant. A statement coming directly from AstraZeneca Plc personnel stated that their standard review process instigated a pause to vaccination, so as to allow the review of their safety data.
The details about what the safety issue is exactly have not yet been made public by neither AstraZeneca nor by the researchers at the University of Oxford, although they mentioned that the patient is not in critical condition and will supposedly, recover soon, according to Stat News.
Molecules for Life- Thioredoxin System
–Esha Sircar & Dr. Rajib Sengupta, Amity Institute of Biotechnology, Amity University Kolkata The thioredoxin (Trx) system is a major antioxidant system that maintains the intracellular redox state. It contains Trx, a redox-active protein, which regulates the activity of various enzymes including those that function to counteract oxidative stress within the cell. Trx, NADPH, and […]